Terms: = Sarcomas AND PPFIBP1, L2, 8496, ENSG00000110841, hSGT2, hSgt2p AND Treatment
36 results:
1. Inhibitory checkpoint molecule mRNA expression in canine soft tissue sarcoma.
Stevenson VB; Gudenschwager-Basso EK; Klahn S; LeRoith T; Huckle WR
Vet Comp Oncol; 2023 Dec; 21(4):709-716. PubMed ID: 37680007
[TBL] [Abstract] [Full Text] [Related]
2. The expression of programmed death-ligand 1 and programmed death-ligand 2 in endometrial carcinosarcoma: Correlation with mismatch repair protein expression status, tumor-infiltrating lymphocyte infiltration, and clinical outcomes.
Atılgan AO; Tepeoğlu M; Özen Ö; Reyhan ANH; Ayhan A
Ann Diagn Pathol; 2023 Aug; 65():152137. PubMed ID: 37060883
[TBL] [Abstract] [Full Text] [Related]
3. Primary intra- and extradural extramedullary mesenchymal chondrosarcoma with isolated punctate calcification: case report and literature review.
Chen M; Lai Q
BMC Neurol; 2022 Mar; 22(1):112. PubMed ID: 35321663
[TBL] [Abstract] [Full Text] [Related]
4. Primary spinal multifocal intradural-extramedullary Ewing sarcoma in children: presentation of a case and review of the literature.
Müngen E; Kurucu N; Kutluk T; Oğuz KK; Söylemezoğlu F; Yalçın B
Turk J Pediatr; 2021; 63(6):1084-1090. PubMed ID: 35023660
[TBL] [Abstract] [Full Text] [Related]
5. Primary osseous chondrosarcoma in the lumbar spine: case report and literature review with analysis.
Tu CH; Chiu YP; Ji HR; Chiu CD
J Int Med Res; 2021 Nov; 49(11):3000605211058890. PubMed ID: 34842480
[TBL] [Abstract] [Full Text] [Related]
6. Associations of PD-L1, PD-L2, and HLA class I expression with responses to immunotherapy in patients with advanced sarcoma: post hoc analysis of a phase 1/2 trial.
Miwa S; Nojima T; Alomesen AA; Ikeda H; Yamamoto N; Nishida H; Hayashi K; Takeuchi A; Igarashi K; Higuchi T; Yonezawa H; Araki Y; Morinaga S; Asano Y; Tsuchiya H
Clin Transl Oncol; 2021 Aug; 23(8):1620-1629. PubMed ID: 33635466
[TBL] [Abstract] [Full Text] [Related]
7. Diagnosis and surgical treatment of primary isolated aggressive lumbar myeloid sarcoma: a rare case report and review of the literatures.
Bai CR; Li X; Wang JS; Li JJ; Liu N; Fei Q; Li D; Yang Y
BMC Musculoskelet Disord; 2021 Feb; 22(1):220. PubMed ID: 33627110
[TBL] [Abstract] [Full Text] [Related]
8. Synovial sarcoma of the spine in the lumbar vertebral body: A rare case report.
Feng Q; Guo P; Wang D; Lv J; Feng J
Medicine (Baltimore); 2020 Dec; 99(50):e23499. PubMed ID: 33327288
[TBL] [Abstract] [Full Text] [Related]
9. Bleeding "sarcomatosis" as a rare presentation of vascular graft-related angiosarcoma: case report and review of the literature.
Presacco S; Agnes AL; Magalini S; Carbone A; Martini M; Agnes A
BMC Surg; 2020 Nov; 20(1):291. PubMed ID: 33218319
[TBL] [Abstract] [Full Text] [Related]
10. A first-in-human phase 1 dose escalation study of spartalizumab (PDR001), an anti-PD-1 antibody, in patients with advanced solid tumors.
Naing A; Gainor JF; Gelderblom H; Forde PM; Butler MO; Lin CC; Sharma S; Ochoa de Olza M; Varga A; Taylor M; Schellens JHM; Wu H; Sun H; Silva AP; Faris J; Mataraza J; Cameron S; Bauer TM
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32179633
[TBL] [Abstract] [Full Text] [Related]
11. NGS-analysis to the rescue: dual checkpoint inhibition in metastatic osteosarcoma - a case report and review of the literature.
Nuytemans L; Sys G; Creytens D; Lapeire L
Acta Clin Belg; 2021 Apr; 76(2):162-167. PubMed ID: 31635553
[No Abstract] [Full Text] [Related]
12. Selective Suppression of Cell Growth and Programmed Cell Death-Ligand 1 Expression in HT1080 Fibrosarcoma Cells by Low Molecular Weight Fucoidan Extract.
Teruya K; Kusumoto Y; Eto H; Nakamichi N; Shirahata S
Mar Drugs; 2019 Jul; 17(7):. PubMed ID: 31331053
[TBL] [Abstract] [Full Text] [Related]
13. Inhibitory effect of MSH6 gene silencing in combination with cisplatin on cell proliferation of human osteosarcoma cell line MG63.
Liu HC; Zeng J; Zhang B; Liu XQ; Dai M
J Cell Physiol; 2019 Jun; 234(6):9358-9369. PubMed ID: 30456894
[TBL] [Abstract] [Full Text] [Related]
14. Diabetic ketoacidosis induced by a single dose of pembrolizumab.
Maamari J; Yeung SJ; Chaftari PS
Am J Emerg Med; 2019 Feb; 37(2):376.e1-376.e2. PubMed ID: 30361152
[TBL] [Abstract] [Full Text] [Related]
15. Primary histiocytic sarcoma of the central nervous system: a case report with platelet derived growth factor receptor mutation and PD-L1/PD-L2 expression and literature review.
May JM; Waddle MR; Miller DH; Stross WC; Kaleem TA; May BC; Miller RC; Jiang L; Strong GW; Trifiletti DM; Chaichana KL; Reimer R; Tun HW; Peterson JL
Radiat Oncol; 2018 Sep; 13(1):167. PubMed ID: 30185195
[TBL] [Abstract] [Full Text] [Related]
16. A phase Ib study of pembrolizumab plus chemotherapy in patients with advanced cancer (PembroPlus).
Weiss GJ; Waypa J; Blaydorn L; Coats J; McGahey K; Sangal A; Niu J; Lynch CA; Farley JH; Khemka V
Br J Cancer; 2017 Jun; 117(1):33-40. PubMed ID: 28588322
[TBL] [Abstract] [Full Text] [Related]
17. Immunotherapy with single agent nivolumab for advanced leiomyosarcoma of the uterus: Results of a phase 2 study.
Ben-Ami E; Barysauskas CM; Solomon S; Tahlil K; Malley R; Hohos M; Polson K; Loucks M; Severgnini M; Patel T; Cunningham A; Rodig SJ; Hodi FS; Morgan JA; Merriam P; Wagner AJ; Shapiro GI; George S
Cancer; 2017 Sep; 123(17):3285-3290. PubMed ID: 28440953
[TBL] [Abstract] [Full Text] [Related]
18. Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma.
George S; Miao D; Demetri GD; Adeegbe D; Rodig SJ; Shukla S; Lipschitz M; Amin-Mansour A; Raut CP; Carter SL; Hammerman P; Freeman GJ; Wu CJ; Ott PA; Wong KK; Van Allen EM
Immunity; 2017 Feb; 46(2):197-204. PubMed ID: 28228279
[TBL] [Abstract] [Full Text] [Related]
19. Immunotherapy as a Potential treatment for Chordoma: a Review.
Patel SS; Schwab JH
Curr Oncol Rep; 2016 Sep; 18(9):55. PubMed ID: 27475804
[TBL] [Abstract] [Full Text] [Related]
20. Thoracolumbar spinal cord tolerance to high dose conformal proton-photon radiation therapy.
Chowdhry VK; Liu L; Goldberg S; Adams JA; De Amorim Bernstein K; Liebsch NJ; Niemierko A; Chen YL; DeLaney TF
Radiother Oncol; 2016 Apr; 119(1):35-9. PubMed ID: 26791929
[TBL] [Abstract] [Full Text] [Related]
[Next]
